TORONTO, ON, Oct. 16, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Tree of Knowledge International Corp. (Tree of Knowledge) (CSE:TOKI) (OTC:TOKIF) expands global medical marijuana and CBD research in partnership with the Caribbean Institute of Pharmacy Policy (CIPPPAR) in Jamaica. Tree of Knowledge will be introducing chronic pain management protocols and research into the Caribbean market. The introduction of these protocols will take the form of clinical trials and research that will include the usage of specific strains of cannabis that aid in chronic pain and cancer treatments.
A key facet in this partnership will be work with the indigenous communities in Jamaica to identify the above mentioned strains. In addition, Tree of Knowledge and CIPPPAR will work together to develop an international, state-of-the-art medical tourism facility in Jamaica to carry out clinical trials and provide pain management services. The partnership will also create certification and training opportunities for Caribbean doctors, pharmacists, nurses and other medical professionals.The Honorable Minister Audley Shaw, Minister of Industry, Commerce, Agriculture and Fisheries for Jamaica, has recognized that Jamaica is positioned to play a leading role globally in the development of value added medical cannabis and CBD products. “We welcome companies such as Tree of Knowledge who are committed to invest and transfer knowledge to our leading researchers in Jamaica on the reduction of opioids through cannabis.”Tree of Knowledge is currently operating in multiple Canadian locations providing education, resources and support to patients and providers across Canada and is excited to be bringing their protocols and learnings to the Caribbean market. “We are very excited with this opportunity to strategically partner with CIPPPAR to help facilitate our shared vision of bringing together expert clinical knowledge, process expertise and available resources to improve the quality of healthcare to patients in Jamaica,” said Gary Prihar, President of Clinical Operations at Tree of Knowledge.Ellen Grizzle, the former Dean of the University of Technology and head of CIPPPAR, recognized that “this is a significant first step that will lead to future business opportunities throughout the Caribbean.”Contact:Tree of Knowledge International Corp.Natasha RaeyMedia RelationsNatasha@tokicorp.com1.778.552.4538Michael CaridiChairmanTel: +1 (917) 295-1374 Michael@tokicorp.comAbout Tree of Knowledge International Corp.With its head office in Toronto, and operations in North York, Ontario and Spokane, Washington, TOKI currently has three primary business segments: (1) Multidisciplinary specialty pain clinics with a focus on the treatment of chronic pain, including controlled applications of medical cannabis in Canada, (2) Development of formulated products for therapeutic purposes and natural health product alternatives at its manufacturing facility in Spokane, which provides formulations for the Company’s products and for third parties equivalent to GMP standards, and (3) Distribution and sale of hemp-based cannabidiol (“CBD”) products in the United States, Canada, Europe, Brazil and Australia. Through its Toronto Poly Clinic, the Company has gleaned extensive expertise from being involved in one of the largest observational clinical trials on medical cannabis and from its ongoing direct patient experience. The Company has developed and implemented MCERP (Medical Cannabis Education, Research and Best Practice Platform) and MCORP (Medical Cannabis Opioid Reduction Program) with great success. Currently, the Company has research agreements with multiple universities for medical cannabis research and new medical grade products development. TOKI’s CBD product line contains EVR Premium Hemp Oil, which is an organically grown and handled, gluten-free, vegan, non-GMO, synergistic compound that is derived from U.S. Department of Agriculture (USDA) approved industrial hemp grown in the United States. TOKI currently offers several CBD products, which may be used in connection with the treatment of a number of ailments and for general wellness purposes.Notice Regarding Forward Looking StatementsThis news release contains “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Canopy Growth or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release. Examples of such statements include “aimed to reduce stigma in the workplace on the use of cannabis as a medicine”, and “content will also include video resources featuring medical cannabis subject matter experts and fact sheets” . Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including content development and such risks contained in the Company’s annual information form dated June 24, 2019 and filed with Canadian securities regulators available on the Company’s issuer profile on SEDAR at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities laws.
Bay Street News